Navigating private equity in health care amid regulatory scrutiny
She joined Leslie C. Overton from Axinn Veltrop & Harkrider LLP and Rebekah Goshorn Jurata of the American Investment Council to discuss the growing antitrust...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
CRA’s economists develop economic analyses on behalf of clients and present these before the U.S. Department of Justice, the Federal Trade Commission, and other government agencies in connection with proposed mergers. We also submit expert reports, deposition testimony, and trial testimony in litigated antitrust cases involving the full gamut of antitrust concerns. Since our work on behalf of IBM in the 1970s, we have worked on many of the most important government and private suits on record, including Sprint/T-Mobile, Apple iPod iTunes Antitrust Litigation, Live Nation/Ticketmaster, US Airways/American Airlines, and CVS/Aetna, to name a few.
Our team of economists includes noted academics and former officials and senior economics staff of the DOJ and FTC. Published research by our competition economists has led to fundamental changes in how economists and antitrust enforcers consider monopolization claims, vertical restraints, and mergers. Our work encompasses a broad range of industries, including, but not limited to, aerospace and defense, computer hardware and software, consumer products, healthcare, insurance products, manufacturing and industrial products, natural resources, online services, telecommunications, entertainment and leisure, and retailing.
She joined Leslie C. Overton from Axinn Veltrop & Harkrider LLP and Rebekah Goshorn Jurata of the American Investment Council to discuss the growing antitrust...
Has the United States economy become less competitive in recent decades? One might think so based on a body of research that has rapidly become influential for...
CRA is a proud sponsor of the event. Liz Bailey is a panelist during the session titled “Expanding merger control tools for non-traditional deals and...
Monica Noether is a panelist during the session on protecting reproductive choice in healthcare and hospital mergers in a post-Dobbs world, part of the Why...